Visit to doctor for prescription refill is not “treatment” for purposes of FMLA

by Ogletree, Deakins, Nash, Smoak & Stewart, P.C.

The Family and Medical Leave Act (FMLA) provides unpaid leave time to eligible employees under specific circumstances, including the serious health condition of the employee. It is a violation of the FMLA for an employer to interfere with an employee’s use or attempted use of FMLA leave time. The 7th U.S. Circuit Court of Appeals has held that an employee who did not receive actual medical treatment during a specific absence could not support an FMLA interference claim for his termination. Jones v. C&D Technologies, Inc., 7th Cir, No. 11-3400, June 28, 2012.

Robert Jones began working for C&D Technologies in 2000 as a machine operator in the company’s Attica, Indiana plant. During the course of his employment, Jones experienced periodic leg and back pain, as well as bouts of anxiety, for which he requested intermittent FMLA leave.

C&D implemented an attendance policy that assigned “points” to absences. For instance, an employee who missed more than four hours of a scheduled shift was assigned one point, while absences lasting less then four hours were assessed one-half a point. Employees also were required to report an absence no later than 30 minutes prior to a shift-start, or an additional one-half point would be added. Points were not assessed for pre-approved FMLA absences. Any employee accumulating one point within a four month period was given a written warning; a second written warning was given to anyone accruing two points in that period; and a third point within that period resulted in termination.

In September 2009, C&D was aware that Jones required periodic treatment for his leg pain and for anxiety. On September 30, Jones spoke to C&D’s FMLA coordinator to request FMLA leave for a 1:00 p.m. appointment at a clinic in Crawfordville, Indiana set for the following day. The coordinator reminded Jones to inform his supervisor of the absence. At that point, Jones already had accumulated 2½ absence points within the prior four months.

On October 1, Jones missed his entire shift. At approximately 10 a.m. on that date, he made an unscheduled visit to his local doctor’s office to confirm that his file had been transferred to the Crawfordsville clinic, and to pick up a prescription refill note. He then drove to Crawfordsville for his 1:00 appointment at the clinic. Whether or not Jones reported his absence to his supervisor is a matter of dispute.

Because of Jones’ October 1 absence, C&D suspended him, pending an investigation, and determined that Jones could have been assessed 1½ points: one point for a full day of absence, and ½ point for failing to report the absence. However, because Jones had a pre-arranged medical appointment on the afternoon of October 1, and because Jones reported leaving a voicemail for his supervisor, he was assessed only ½ point for his absence during the morning of October 1. That one-half point took his total points to three, leading to his discharge.

Jones filed a lawsuit, arguing that his absence on the morning of October 1 was for “treatment” for his serious health condition, because it involved obtaining a prescription for medication. The lower court determined that Jones’ morning errands on October 1 did not constitute treatment as a matter of law, and awarded summary judgment to C&D. Jones appealed that decision.

The Seventh Circuit upheld the dismissal. It pointed out that the FMLA entitles an employee to leave if the employee suffers from a serious health condition that “makes the employee unable to perform the functions of [his] position.” The DOL regulations define an employee unable to perform his duties as one “who must be absent from work to receive medical treatment for a serious health condition.” The word “must” implies that the employee’s absence is necessary for the treatment. Alternatively, an absence for unnecessary treatment, or for no treatment at all, means that the employee is not “unable to perform” the functions of his position. Therefore, Jones’ situation revolved around the definition of “treatment.”

According to the Seventh Circuit, while the DOL’s definition of “treatment” includes the phrase “a course of prescription medication,” the FMLA requires something more than that to become entitled to leave – the actual inability to perform job functions. Jones’ absence was not based upon his inability to do his job. Instead, on the morning of October 1, he made an unscheduled visit to his doctor to check on medical records and to ask for a prescription refill. His doctor did not examine him, or treat him, and spoke only briefly to him. There was no “treatment” provided and, therefore, no FMLA-qualifying leave.

Employers should recognize that this case cannot be interpreted to exclude every medical visit from FMLA leave when one reason for the visit was obtaining prescription medication. Instead, the entire purpose of the visit to the physician must be assessed, and viewed in the light of the employee’s FMLA-qualifying medical condition. If, in fact, “treatment” is being provided, the absence is likely to be deemed FMLA leave.


DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Ogletree, Deakins, Nash, Smoak & Stewart, P.C. | Attorney Advertising

Written by:

Ogletree, Deakins, Nash, Smoak & Stewart, P.C.

Ogletree, Deakins, Nash, Smoak & Stewart, P.C. on:

Readers' Choice 2017
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up using*

Already signed up? Log in here

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Privacy Policy (Updated: October 8, 2015):

JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources. Our policies with regard to data collection and use of personal information of users of the Service, regardless of the manner in which users access the Service, and visitors to the Website are set forth in this statement ("Policy"). By using the Service, you signify your acceptance of this Policy.

Information Collection and Use by JD Supra

JD Supra collects users' names, companies, titles, e-mail address and industry. JD Supra also tracks the pages that users visit, logs IP addresses and aggregates non-personally identifiable user data and browser type. This data is gathered using cookies and other technologies.

The information and data collected is used to authenticate users and to send notifications relating to the Service, including email alerts to which users have subscribed; to manage the Service and Website, to improve the Service and to customize the user's experience. This information is also provided to the authors of the content to give them insight into their readership and help them to improve their content, so that it is most useful for our users.

JD Supra does not sell, rent or otherwise provide your details to third parties, other than to the authors of the content on JD Supra.

If you prefer not to enable cookies, you may change your browser settings to disable cookies; however, please note that rejecting cookies while visiting the Website may result in certain parts of the Website not operating correctly or as efficiently as if cookies were allowed.

Email Choice/Opt-out

Users who opt in to receive emails may choose to no longer receive e-mail updates and newsletters by selecting the "opt-out of future email" option in the email they receive from JD Supra or in their JD Supra account management screen.


JD Supra takes reasonable precautions to insure that user information is kept private. We restrict access to user information to those individuals who reasonably need access to perform their job functions, such as our third party email service, customer service personnel and technical staff. However, please note that no method of transmitting or storing data is completely secure and we cannot guarantee the security of user information. Unauthorized entry or use, hardware or software failure, and other factors may compromise the security of user information at any time.

If you have reason to believe that your interaction with us is no longer secure, you must immediately notify us of the problem by contacting us at In the unlikely event that we believe that the security of your user information in our possession or control may have been compromised, we may seek to notify you of that development and, if so, will endeavor to do so as promptly as practicable under the circumstances.

Sharing and Disclosure of Information JD Supra Collects

Except as otherwise described in this privacy statement, JD Supra will not disclose personal information to any third party unless we believe that disclosure is necessary to: (1) comply with applicable laws; (2) respond to governmental inquiries or requests; (3) comply with valid legal process; (4) protect the rights, privacy, safety or property of JD Supra, users of the Service, Website visitors or the public; (5) permit us to pursue available remedies or limit the damages that we may sustain; and (6) enforce our Terms & Conditions of Use.

In the event there is a change in the corporate structure of JD Supra such as, but not limited to, merger, consolidation, sale, liquidation or transfer of substantial assets, JD Supra may, in its sole discretion, transfer, sell or assign information collected on and through the Service to one or more affiliated or unaffiliated third parties.

Links to Other Websites

This Website and the Service may contain links to other websites. The operator of such other websites may collect information about you, including through cookies or other technologies. If you are using the Service through the Website and link to another site, you will leave the Website and this Policy will not apply to your use of and activity on those other sites. We encourage you to read the legal notices posted on those sites, including their privacy policies. We shall have no responsibility or liability for your visitation to, and the data collection and use practices of, such other sites. This Policy applies solely to the information collected in connection with your use of this Website and does not apply to any practices conducted offline or in connection with any other websites.

Changes in Our Privacy Policy

We reserve the right to change this Policy at any time. Please refer to the date at the top of this page to determine when this Policy was last revised. Any changes to our privacy policy will become effective upon posting of the revised policy on the Website. By continuing to use the Service or Website following such changes, you will be deemed to have agreed to such changes. If you do not agree with the terms of this Policy, as it may be amended from time to time, in whole or part, please do not continue using the Service or the Website.

Contacting JD Supra

If you have any questions about this privacy statement, the practices of this site, your dealings with this Web site, or if you would like to change any of the information you have provided to us, please contact us at:

- hide
*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.